Skip to content
Medical Health Aged Care

InMode launches the “Lift & Glow” Protocol powered by In Mode Boost in Australia: A game-changing aesthetic breakthrough for clinics and patients.

InMode Australia 3 mins read

InMode Australia has announced the national launch of its comprehensive new protocol, Lift & Glow powered by InMode Boost, a structured, multi-modality aesthetic treatment that is transforming both faces and clinic revenues across the globe.

Developed in conjunction with award-winning dermatologist Dr. Alma Kamenica of Vienna, Austria, Lift & Glow combines InMode’s most advanced technologies—Morpheus8 Burst (RF micro-needling), Lumecca Peak (IPL), and Forma (RF skin tightening)—into a 12-week treatment protocol designed to deliver visible, natural-looking facial rejuvenation and tightening with no injectables and zero downtime.

“This is more than a treatment—it's a complete patient journey that delivers excellent clinical results, boosts patient and clinic loyalty, and powers clinic growth,” says InMode Australia Managing Director, Dennis Cronje.

A protocol that performs - medically and commercially

Each Lift & Glow journey includes:

  • 3 Morpheus8 Burst sessions for contouring and collagen remodelling
  • 3 Lumecca Peak IPL sessions for pigmentation, redness, and skin clarity
  • 6 Forma RF skin tightening sessions

Designed for operational efficiency, the protocol allows clinics to streamline scheduling, improve equipment utilisation, and deliver consistent, high-impact results that foster patient loyalty and drive brand equity.

“Lift & Glow, powered by InMode Boost, is to aesthetics what Chanel is to fashion - a premium, proven signature experience,” says Dr. Kamenica.

Official launch dates

Dr Alma Kamenica will be presenting live at the ASAPS Non-Surgical Symposium (NSS) to be held on the Gold Coast 13-15th June, 2025. She will unveil Lift & Glow - a game-changing protocol powered by InMode Boost.

In addition, Dr Alma will undertake a 4-city Australian Masterclass Tour, where she will share in detail the Lift & Glow Protocol powered by InMode Boost, step-by-step insights, live demos, and business applications.

Masterclass Australian Tour Dates

  • Brisbane Masterclass – Thursday 12th June from 6:30pm – Calile Hotel with guest speaker Dr KC Tee from Arte Skin and Aleksander Josipovic, The Dark Ink
  • Sydney Masterclass – Monday 16th June from 6:30pm – Doltone House with guest speaker Dr Jean-Paul Chung and Aleksander Josipovic, The Dark Ink
  • Melbourne Masterclass – Wednesday 18th June from 6:30pm – Crown Melbourne with guest speaker Dr Tim Hsu from Vena Clinic
  • Perth Masterclass – Friday 20th June from 6:30pm – QT Hotel with guest speaker Dr Aleksandra Kaddour from OLA Aesthetics and Aleksander Josipovic, The Dark Ink

To reserve your tickets or to find out more about the Lift & Glow protocol powered by InMode Boost, visit www.inmode.com.au/liftandglow

 

About Dr Alma Kamenica

Dr Alma Kamenica is a board-certified dermatologist and founder of a private dermatology practice in Vienna, Austria. With over a decade of clinical experience, she has served as a senior physician and head of the Dermatological Laser Department at Wiener Neustadt. 

Dr Kamenica is internationally recognised for her expertise in aesthetic and laser dermatology, frequently lecturing at leading global congresses including AMWC Monte Carlo, Korea Derma, and IMCAS. She is also a finalist in the 2025 AMWC Aesthetic Medicine Awards in the category of Best Energy-Based Treatment. 

Passionate about combining science with aesthetics, Dr Alma is a trusted key opinion leader for InMode and continues to contribute to advancing dermatological care through education and innovation.


About us:

About InMode Australia

InMode is a leading global provider of innovative medical aesthetic technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology, light-based applications including IPL and laser, and EMS. InMode strives to enable new emerging non-surgical procedures as well as improving and complimenting existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories including plastic and cosmetic surgery, dermatology, optometry and ophthalmology, gynaecology, women’s health, and cosmetic clinics.


Contact details:

For media inquiries, please contact:

Marton Jakab
Head of Marketing - InMode Australia
Phone: (02) 7209 5678
Mobile: 0477 884 773
Email:
[email protected]
Website:
www.inmode.com.au

Note to Editors: High-resolution images and additional information are available upon request.

More from this category

  • Medical Health Aged Care
  • 12/12/2025
  • 10:11
Cosette Pharmaceuticals, Inc.

Termination of Proposed Acquisition of Mayne Pharma

BRIDGEWATER, N.J.–BUSINESS WIRE– Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on…

  • Contains:
  • Medical Health Aged Care
  • 12/12/2025
  • 08:55
Royal Australian College of GPs

Universal Health Coverage Day: RACGP calls out need for better funding for chronic conditions and preventive care

Specialist GPs have marked International Universal Health Coverage (UHC) Day by joining the World Health Organization in highlighting the devastating impact of health costs. The Royal Australian College of GPs (RACGP) has stressed that a public health system which forces patients with complex or chronic conditions to pay out of pocket for longer consultations can’t claim to offer universal coverage, and urged governments to protect patients from financial hardship. “Health is a human right,” RACGP President Dr Michael Wright said. “Australia recognises the right of everyone to the highest attainable standard of physical and mental health, and our governments are…

  • Contains:
  • Medical Health Aged Care, Women
  • 12/12/2025
  • 01:00
Breast Cancer Trials

Simple blood tests could help tailor treatment for aggressive breast cancer

Key Facts: Blood tests detecting circulating tumour DNA could help guide treatment for triple negative breast cancer patients Absence of tumour DNA in blood…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.